Détail de la notice
Titre du Document
Acetato de megestrol en pacientes con síndrome de caquexia-anorexia por neoplasia avanzada
Megestrol acetate in patient with caquexia-anorexia syndrome caused by advanced neoplasia
Auteur(s)
TUCA A. ; ANGUERA A.
Résumé
Introduction: the caquexia-anorexia syndrome is present in almost 70% of the patients with terminal neoplasia, including it can be present in earlier stages. It has a very big repercussion as well in the physical as psychical condition. It was observed that the megestrol acetate produces a stimulus of the appetite and an increase of the weight in patients with anorexia and/or caquexia in patients with different types of cancer. Method: it was carried out an observational study to evaluate the effect of megestrol acetate using several parameters to evaluate the nutritional conditions. The principal variables were: increase of weight, subjective feeling of increase of weight, using a visual analogical scale, the body mass index and the weight referred to desirable weight. Results: it has been included a total of 103 patients. The mean age was 62.6 years. Seventy of the patients were male and 33 were women. The patients were treated with diary doses of megestrol acetate between 480 and 320 mg/day. The duration of the treatment was of 4 months. It has been observed a significant increase of weight of 1.78 kg, already at the second month of treatment with megestrol acetate. This increase was of 2.85 kg (p< 0.001) at the 4 month of treatment. Th body mass index was also increased siginficatively as in the two months as in the four months of treatment with megestrol acetate (p<0.001). Referring to the subjective feeling of appetite, measured by an analogical scale, it was observed a
Editeur
Aràn
Identifiant
ISSN : 1134-248X
Source
Medicina paliativa A. 2002, vol. 9, n° 2, pp. 71-76 [6 pages]
Langue
Espagnol
Pour les membres de la communauté du CNRS, ce document est autorisé à la reproduction à titre gratuit.
Pour les membres des communautés hors CNRS, la reproduction de ce document à titre onéreux sera fournie sous réserve d’autorisation du Centre Français d’exploitation du droit de Copie.

Pour bénéficier de nos services (strictement destinés aux membres de la communauté CNRS (Centre National de la Recherche Scientifique), de l'ESR français (Enseignement Supérieur et Recherche), et du secteur public français & étranger) :